These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. BMJ; 1991 Jan 26; 302(6770):210-6. PubMed ID: 1998761 [Abstract] [Full Text] [Related]
5. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Laffel LM, McGill JB, Gans DJ. Am J Med; 1995 Nov 26; 99(5):497-504. PubMed ID: 7485207 [Abstract] [Full Text] [Related]
6. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT). Diabetes; 2001 Apr 26; 50(4):843-50. PubMed ID: 11289051 [Abstract] [Full Text] [Related]
7. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Ahmad J, Siddiqui MA, Ahmad H. Diabetes Care; 1997 Oct 26; 20(10):1576-81. PubMed ID: 9314638 [Abstract] [Full Text] [Related]
8. [The effect of perindopril in treatment of early diabetic nephropathy with normal blood pressure and microalbuminuria]. Yao B, Hu G, Li Y, Liao Z, Zhang Y. Zhonghua Nei Ke Za Zhi; 2001 Dec 26; 40(12):826-8. PubMed ID: 16206673 [Abstract] [Full Text] [Related]
9. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212 [Abstract] [Full Text] [Related]
10. Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus. Kvetny J, Gregersen G, Pedersen RS. QJM; 2001 Feb 21; 94(2):89-94. PubMed ID: 11181984 [Abstract] [Full Text] [Related]
13. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics. BENEDICT Group. Control Clin Trials; 2003 Aug 21; 24(4):442-61. PubMed ID: 12865039 [Abstract] [Full Text] [Related]
14. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):982-8. PubMed ID: 9625684 [Abstract] [Full Text] [Related]
15. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS. Kidney Int; 2000 Feb 15; 57(2):590-600. PubMed ID: 10652036 [Abstract] [Full Text] [Related]
16. PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease. Fici F, Ari Bakir E, Ilkay Yüce E, Kanuncu S, Makel W, Tarim BA, Robles NR. High Blood Press Cardiovasc Prev; 2020 Feb 15; 27(1):43-49. PubMed ID: 31916208 [Abstract] [Full Text] [Related]
17. Renal function, glycemic control and perindopril in diabetic patients. Brichard S, Ketelslegers JM, Lambert AE. Clin Exp Hypertens A; 1989 Feb 15; 11 Suppl 2():545-54. PubMed ID: 2691128 [Abstract] [Full Text] [Related]
18. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. Leoncini G, Martinoli C, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Derchi LE, Deferrari G, Pontremoli R. Nephron; 2002 Feb 15; 90(2):169-73. PubMed ID: 11818701 [Abstract] [Full Text] [Related]
19. Systematic review on urine albumin testing for early detection of diabetic complications. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C. Health Technol Assess; 2005 Aug 15; 9(30):iii-vi, xiii-163. PubMed ID: 16095545 [Abstract] [Full Text] [Related]
20. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. Cooper ME. J Hypertens Suppl; 1996 Dec 15; 14(6):S11-4. PubMed ID: 9023709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]